SCHEDULE 13G

Company

Caribou Biosciences, Inc.

Filed

February 28, 2017

Accession Number

0001654954-17-001508

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →